Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism

Direct-acting oral anticoagulants (DOACs) are prescribed in the treatment of venous thromboembolism, including pulmonary embolism (PE). Evidence is limited regarding the outcomes and optimal timing of DOACs in patients with intermediate- or high-risk PE treated with thrombolysis. We conducted a retr...

Full description

Bibliographic Details
Main Authors: Adam Wolfe MD, Angela Phillips MD, David M Tierney MD, FACP, Roman Melamed MD, FCCP, Ghazi Qadri MD, Matthew Lillyblad PharmD, BCCCP, BCCP, Claire Smith MS, Catherine St. Hill DVM, PhD, Ashley E Stenzel PhD, David Beddow MD, Justin Kirven MD, Rajesh Kethireddy MD, Love Patel MD, SFHM
Format: Article
Language:English
Published: SAGE Publishing 2023-03-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296231156414

Internet

https://doi.org/10.1177/10760296231156414

Similar Items